Thanks to an exceptional and mutual collaboration between bioXclusters plus and the EU-Japan Centre, around 60 participants from nine different European countries (Austria, France, Germany, Greece, Italy, Netherlands, Spain, Sweden and UK) participated in the joint mission to Osaka and Yokohama which took place from 10th to 14th October 2016.On 10th October, the delegation attended lectures and presentations given by experts about business opportunities in the Japanese healthcare sector. These were organised in cooperation with the EU Japan Centre. On the 2nd day of the mission, the delegation participated in the dedicated “European Biotech & Pharma Partnering Conference”, co-organised by Osaka Bio Headquarters and bioXclusters plus. This conference took place at the Senri-Life Science Center in Osaka, once again with the support of the EU Japan Centre. At this conference, EU participants had the opportunity to meet with potential Japanese partners. Thanks to the Enterprise Europe Network who had set up pre-arranged meetings using the matchmaking platform (https://www.b2match.eu/EUJ-bio-pharma-BE-2016) before the event, a total of 288 B2B meetings were held with 61 Japanese companies and organisations from the Kansai region.
During the last three days of the mission, the joint delegation attended the Bio Japan Expo in Yokohama. On 13th October at the Bio Cluster summit organised by the Japan Bioindustry Association (JBA), the bioXclusters plus partners introduced their initiative to Japan.
As next steps in the following months, bioXclusters plus intends to build a “direct Gateway” to Japan for its European SMEs and, in this way, help to reinforce their market access and to foster and fast-track business relationships. One of its initiatives will include the organisation of a dedicated “EU Japan cluster matchmaking event” to take place at Bio-Europe 2016 in Cologne (more information to come).
The bioXclusters plus delegation to Japan was composed of representatives from the four partner clusters and 26 SMEs from their regions. SME participants included 2bind GmbH, 4SC AG, Ability Pharmaceuticals S.L., Apceth GmbH & Co. KG, Ascenion GmbH, Bioindustry Park Silvano Fumero SpA, Boeters &LieckCoriolis Pharma Research GmbH, CTIBiotech, CYTOO SA, FGK Clinical Research GmbH, Gams Wellness, genOway, Indicia Production, Iris Biotech GmbH, Klifovet AG, Laboratorios Rubió S.A, Laboratorios Salvat S.A., Leukocare AG, Leukos Biotech, Medigene AG, Mind the Byte S.L., Novotec, Theranexus, Thrombotargets Europe S.L., and Zeclinics S.L.
You can find more information about the participating SMEs in this brochure: bioxclusters plus Delegation brochure – Japan Mission